requip depot 8 mg
glaxosmithkline as - ropinirolhydroklorid - depottablett - 8 mg
taptiqom 15 mikrog/ ml / 5 mg/ ml
santen oy - tafluprost / timololmaleat - Øyedråper, oppløsning i endosebeholder - 15 mikrog/ ml / 5 mg/ ml
fluarix tetra
glaxosmithkline as - influensa a-virus (h1n1), inaktivert, splittvirus / influensa a-virus (h3n2), inaktivert, splittvirus / influensa b-virus, victoria-linje, inaktivert, splittvirus / influensa b-virus, yamagata-linje, inaktivert, splittvirus - injeksjonsvæske, suspensjon i ferdigfylt sprøyte - 15 mikrog ha / 15 mikrog ha / 15 mikrog ha / 15 mikrog ha
galliad -
ire-elit - gallium (68ga) klorid / germanium(68ge)klorid - radionuklidegenerator
latuda 18.5 mg
2care4 aps - lurasidonhydroklorid - tablett, filmdrasjert - 18.5 mg
latuda 37 mg
orifarm as - lurasidonhydroklorid - tablett, filmdrasjert - 37 mg
latuda 37 mg
2care4 aps - lurasidonhydroklorid - tablett, filmdrasjert - 37 mg
latuda 74 mg
2care4 aps - lurasidonhydroklorid - tablett, filmdrasjert - 74 mg
pamorelin 22.5 mg
institut produits synthèse (ipsen) ab - triptorelinembonat - pulver og væske til depotinjeksjonsvæske, suspensjon - 22.5 mg
apexxnar
pfizer europe ma eeig - pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 8, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 10a, pneumococcal polysaccharide serotype 11a, pneumococcal polysaccharide serotype 12f, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 15b, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal polysaccharide serotype 19f, pneumococcal polysaccharide serotype 22f, pneumococcal polysaccharide serotype 23f, pneumococcal polysaccharide serotype 33f - pneumokokkerinfeksjoner - vaksiner - active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. se avsnitt 4. 4 og 5. 1 for informasjon om beskyttelse mot spesifikke pneumokokserotyper. apexxnar should be used in accordance with official recommendations. .